Fourth Cross Border Healthcare Conference
Apskatīt komentārus (0)
04.07.2014
See full information at http://www.eu-patient.eu/Events/Cross-Border-Healthcare-Conference-6-8-October-Tallinn-Estonia/
What? With this conference, you will hopefully learn and share experiences about how the Directive works for patients and how you can contribute a strong patients perspective.
Objective
To build knowledge about the Cross-Border Healthcare Directive and patients rights enshrined within this legislation;
To ensure understanding about the scope of the Directive and its application at national level;
To exchange views on those aspects of the Directive that will be particularly important and/or challenging for you in your national contexts;
To explore various facets of the Directive which have wider policy and systems implications of interest to you (eHealth provision, HTA provision, general provisions on Quality of Care and Patient Safety, specific provisions linked to Rare Diseases, etc.);
To share and discuss good practices for the implementation of the Directive;
To facilitate greater understanding regarding the role of National Contact Points in your country and how patient groups could support their effectiveness;
To agree an approach to evaluate the impact of the legislation from a patients perspective;
To create an informal network of patient leaders interested and committed in CBHC to monitor developments over the coming years.
Expected outcomes
To learn and share experiences about the implications of the Directive for patients and national healthcare as a whole;
To promote better health policy and health outcomes at national level by building Patient Organisations capacities in getting your message through as a collective voice;
To strengthen patients organisations advocacy skills to increase your impact in policy and decision-making at national and European level;
To strengthen patients organisations communication skills to increase visibility at national level and get your message across;
To increase cooperation between patient organisations within and across the five eligible countries.
